CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
57 hedge funds and large institutions have $63.3M invested in Cascadian Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
-19
Holders Change %
-25%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
16
Reduced
31
Closed
23
Calls
$625K
Puts
$86K
Net Calls
+$539K
Net Calls Change
+$351K
